A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|27|1|78-86

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.27, Iss.1, 2018-01, pp. : 78-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is a Dexamethasone-Sparing Strategy Capable of Preventing Acute and Delayed Emesis Caused by Combined Doxorubicin and Paclitaxel for Breast Cancer? Analysis of a Phase II Trial

By  

Oncology, Vol. 84, Iss. 6, 2013-05 ,pp. : 371-377

Karger

Access to resources Recommend Favorite

The use of gene arrays and corresponding connectivity mapping (Cmap) to identify novel anti‐ageing ingredients

By  

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Vol. 37, Iss. S1, 2015-10 ,pp. : 9-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Antidepressant Medications and the Possible Association with Breast Cancer Risk

By  

Psychotherapy and Psychosomatics, Vol. 72, Iss. 4, 2003-06 ,pp. : 185-194

Karger

Access to resources Recommend Favorite

Preventing familial breast and ovarian cancer: major research advances with little implication

By Ziogas Dimosthenis E   Katsios Christos S   Roukos Dimitrios H  

Women's Health, Vol. 7, Iss. 2, 2011-03 ,pp. : 135-138

Future Medicine

Access to resources Recommend Favorite

Preventing Errors Associated with Loading Doses of Medications

By  

Joint Commission: The Source, Vol. 11, Iss. 1, 2013-01 ,pp. : 1-5

Joint Commission Resources

Access to resources Recommend Favorite